D-RSBI vs RSBI to predict weaning success in COPD patients
Official title: Diaphragmatic Rapid Shallow Breathing Index (D-RSBI) Versus Traditional Rapid Shallow Breathing Index (RSBI) for Prediction of Weaning Success From Mechanical Ventilation in COPD Patients
Run by Sohag University · NCT07590362 · Data updated 2026-11-12
This study tests whether diaphragmatic rapid shallow breathing index (D-RSBI) can better predict which COPD patients on mechanical ventilation will successfully wean than the traditional RSBI.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag, Sohag Governorate) |
| Status | Recruiting |
| Started | April 15, 2026 |
| Main results expected | May 2027 |
| Study ends | June 2027 |
| Registry record updated | May 15, 2026 |
| Trial ID | NCT07590362 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Mechanically ventilated COPD patients who are ready for spontaneous breathing trials and meet the stated inclusion criteria.
✕Probably not a fit
Patients with diaphragmatic pathology, neuromuscular disease, or poor ultrasound windows may not benefit from D-RSBI assessment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational cohort compares two weaning indices—D-RSBI measured by diaphragmatic ultrasound and the traditional RSBI—in COPD patients undergoing spontaneous breathing trials. Participants are mechanically ventilated for more than 24 hours and meet standard readiness criteria, with diaphragmatic ultrasound performed during SBTs and follow-up for 72 hours after extubation to determine weaning outcomes. The study is conducted at Sohag University Hospital, with data collected on predictor accuracy and timing to successful extubation. Inclusion requires stable hemodynamics, adequate oxygenation, and the ability to initiate spontaneous breathing; exclusions include neuromuscular disorders, diaphragmatic pathology, or poor ultrasound windows.
Why it matters
Potential benefit: If successful, D-RSBI could provide a more accurate predictor of weaning readiness, potentially reducing ventilation time and associated risks.
How similar studies have gone: Prior work on diaphragmatic ultrasound and weaning indices has shown promise, but direct head-to-head comparisons like this are limited in COPD populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Mechanically ventilated COPD patients fulfilling standard weaning readiness criteria. * Invasive mechanical ventilation for more than 24 hours before spontaneous breathing trial. * Hemodynamically stable without significant vasopressor support. * Adequate oxygenation with FiO2 ≤ 0.5 and PEEP ≤ 8 cmH2O . * Preserved mental status and ability to initiate spontaneous breathing. * Successful tolerance of spontaneous breathing trial conducted on CPAP mode with pressure support ≤ 8 cmH2O. Exclusion Criteria: * Refusal of consent * Neuromuscular disease, phrenic nerve palsy, or diaphragmatic paralysis. * Large pneumothorax or pathology interfering with ultrasound assessment. * Terminal extubation. * Recent major thoracic surgery. * Poor sonographic window despite repeated attempts.
Where it's running
-
Sohag University Hospital
Sohag, Sohag Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Ahmed Atef Mohamed, MBBCh
- Email: ahmed_ateff_post@med.sohag.edu.eg
- Phone: +201006973892
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
-
Targeted NMES to improve breathing and leg/extra muscle strength in COPD
This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
PBMT with a pulmonary rehab program for COPD patients
A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.
-
Controlled versus standard oxygen therapy for ICU COPD with acute exacerbation
This trial tests whether keeping oxygen levels at 88-92% helps ICU patients with an acute COPD flare more than keeping levels above 94%.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.